Tirzepatide GLP-1 medication may be most effective for weight loss
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the University of Georgia.
Jun 15, 2026
0
15
Clinical pharmacology news
Three-in-one vaccine shows promise against 'tripledemic'
Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of seasonal influenza, COVID-19 and respiratory syncytial virus (RSV). That may mean the flu shot needs ...
Jun 29, 2026
0
15
Leucovorin prescriptions for children rise 46% after federal officials' autism claims
Leucovorin prescriptions for children spiked after federal officials claimed the drug was an effective treatment for autism during a September 2025 press conference, according to a new Michigan Medicine-led study published ...
Aug 12, 2026
0
15
Scientists develop microRNA-based gene therapy that halts ALS progression in mice
A single IV injection of a microRNA-based biologic developed by Guangping Gao, Ph.D., Robert H. Brown Jr., DPhil, MD, Jun Xie, Ph.D., and Zuoshang Xu, MD, Ph.D., suppressed production of the mutant SOD1 protein that causes ...
Jul 29, 2026
0
14
Patient-derived organoids reveal which breast tumors may resist standard therapies
Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown ...
Aug 10, 2026
0
14
Dementia-causing substance turns into a therapeutic 'switch' with new Alzheimer's drug strategy
A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new therapeutic approach that uses hydrogen peroxide (H₂O₂), a reactive oxygen species that damages cells ...
Jul 2, 2026
0
14
New targeting method separates opioid pain relief from reward learning in mice
Researchers at Duke University School of Medicine are investigating how to keep opioids' pain-relieving benefits while reducing their addictive potential. In a study published in Nature, they report a step toward that goal.
Aug 9, 2026
0
14
FDA approves Simtriyo for treating ADHD in children and adults
The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and older weighing ≥20 kg.
Jul 30, 2026
0
14
Researchers find doctors played a critical role in the nation's opioid crisis
The official sum of opioid-related settlements between U.S. state and local governments and major pharmaceutical opioid manufacturers, marketers, distributors and retailers recently reached $58.58 billion. Stark statistics ...
Jul 16, 2026
0
14
Low-cost treatment for multiple sclerosis shown to be as effective as standard therapy
A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B-cell-depleting therapy, is as effective as ocrelizumab in newly diagnosed relapsing multiple sclerosis ...
Jul 2, 2026
0
14
